News related to Acular (Ketorolac Ophthalmic) and/or conditions it is approved for
Diabetic Macular Edema: Changing Treatment Paradigms
Source: Medscape Ophthalmology Headlines [2014.11.10]
Find out how paradigms for treating diabetic macular edema are evolving.
Current Opinion in Ophthalmology
Advance of macular degeneration can be predicted by retinal-scan analysis
Source: Eye Health / Blindness News From Medical News Today [2014.11.08]
Stanford University School of Medicine scientists have found a new way to forecast which patients with age-related macular degeneration are likely to suffer from the most debilitating form of the...
Progression of age-related macular degeneration in 1 eye then other eye
Source: Eye Health / Blindness News From Medical News Today [2014.10.23]
Having age-related macular degeneration (AMD) in one eye was associated with an increased incidence of AMD and accelerated progression of the debilitating disease in the other eye.
Source: MedicineNet Tonometry Specialty [2014.01.23]
Title: Macular Degeneration
Category: Diseases and Conditions
Created: 7/23/1999 6:05:00 PM
Last Editorial Review: 1/23/2014 12:00:00 AM
Jetrea Gets FDA Nod for Macular Adhesion
Source: MedPage Today Product Alert [2012.10.19]
WASHINGTON -- The FDA has approved ocriplasmin (Jetrea) as the first nonsurgical treatment for symptomatic vitreomacular adhesion.
'Miniature Telescope' for Eye Approved for Macular Degeneration
Source: MedicineNet Macular Degeneration (Age-Related Type) Specialty [2010.07.07]
Title: 'Miniature Telescope' for Eye Approved for Macular Degeneration
Category: Health News
Created: 7/6/2010 2:10:00 PM
Last Editorial Review: 7/7/2010
How Nigeria prevented an Ebola epidemic
Source: Tropical Diseases News From Medical News Today [2014.10.22]
WHO have declared Nigeria free of Ebola virus transmission and describe the country's successful prevention of an unimaginable epidemic as a spectacular story worth telling.
Ruboxistaurin (RBX) may reduce risk of vision loss in diabetics
Source: The Doctors Lounge - Endocrinology and Diabetes
Phase III trial demonstrates ruboxistaurin (RBX) may reduce the risk of vision loss especially in diabetic macular edema.